Terms: = Germ cell tumor AND CCNE1, CCNE, 898, ENSG00000105173, P24864 AND Treatment
36 results:
1. CircROR1 upregulates ccne1 expression to promote melanoma invasion and metastasis by recruiting KAT2A.
Sun L; Bin S; Huang C; Wang Q
Exp Dermatol; 2024 Apr; 33(4):e15071. PubMed ID: 38566477
[TBL] [Abstract] [Full Text] [Related]
2. Regulation of cell Cycle Progression through RB Phosphorylation by Nilotinib and AT-9283 in Human Melanoma A375P cells.
Pham TM; Ahmed M; Lai TH; Bahar ME; Hwang JS; Maulidi RF; Ngo QN; Kim DR
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474202
[TBL] [Abstract] [Full Text] [Related]
3. Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study.
Subbiah V; Hu MI; Mansfield AS; Taylor MH; Schuler M; Zhu VW; Hadoux J; Curigliano G; Wirth L; Gainor JF; Alonso G; Adkins D; Godbert Y; Ahn MJ; Cassier PA; Cho BC; Lin CC; Zalutskaya A; Barata T; Trask P; Scalori A; Bordogna W; Heinzmann S; Brose MS
Thyroid; 2024 Jan; 34(1):26-40. PubMed ID: 38009200
[No Abstract] [Full Text] [Related]
4. tumor-suppressive microRNA-152 inhibits the proliferation of Ewing's sarcoma cells by targeting CDK5R1.
Kawano M; Tanaka K; Itonaga I; Iwasaki T; Kubota Y; Tsumura H
Sci Rep; 2023 Oct; 13(1):18546. PubMed ID: 37899376
[TBL] [Abstract] [Full Text] [Related]
5. Effects of treatment methods on cutaneous melanoma related mortality and all-cause mortality in Texas: TCR-Medicare 2007-2017 database.
Ramirez F; Riva H; Digbeu B; Samaniego M; Fernandez L; Mansour S; Vasquez R; Lopez DS; Chacon J
Cancer Causes Control; 2024 Feb; 35(2):265-275. PubMed ID: 37702966
[TBL] [Abstract] [Full Text] [Related]
6. Integrative Analysis of a Large Real-World Cohort of Small cell Lung Cancer Identifies Distinct Genetic Subtypes and Insights into Histologic Transformation.
Sivakumar S; Moore JA; Montesion M; Sharaf R; Lin DI; Colón CI; Fleishmann Z; Ebot EM; Newberg JY; Mills JM; Hegde PS; Pan Q; Dowlati A; Frampton GM; Sage J; Lovly CM
Cancer Discov; 2023 Jul; 13(7):1572-1591. PubMed ID: 37062002
[TBL] [Abstract] [Full Text] [Related]
7. Diffuse Large B-cell Epstein-Barr Virus-Positive Primary CNS Lymphoma in Non-AIDS Patients: High Diagnostic Accuracy of DSC Perfusion Metrics.
Pons-Escoda A; García-Ruíz A; Naval-Baudin P; Grussu F; Viveros M; Vidal N; Bruna J; Plans G; Cos M; Perez-Lopez R; Majós C
AJNR Am J Neuroradiol; 2022 Nov; 43(11):1567-1574. PubMed ID: 36202547
[TBL] [Abstract] [Full Text] [Related]
8. [Value of tumor growth rate in evaluating the early therapeutic efficacy of neuroendocrine neoplasm].
Zhou YT; Xia YF; Li Y; Zhu YJ; Chi Y; Jiang L
Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(14):1000-1006. PubMed ID: 35399019
[No Abstract] [Full Text] [Related]
9. BAP1-defficient breast cancer in a patient with BAP1 cancer syndrome.
Blatnik A; Ribnikar D; Šetrajčič Dragoš V; Novaković S; Stegel V; Grčar Kuzmanov B; Boc N; Perić B; Škerl P; Klančar G; Krajc M
Breast Cancer; 2022 Sep; 29(5):921-927. PubMed ID: 35381901
[TBL] [Abstract] [Full Text] [Related]
10. Association of Cutaneous Immune-Related Adverse Events With Increased Survival in Patients Treated With Anti-Programmed cell Death 1 and Anti-Programmed cell Death Ligand 1 Therapy.
Tang K; Seo J; Tiu BC; Le TK; Pahalyants V; Raval NS; Ugwu-Dike PO; Zubiri L; Naranbhai V; Carrington M; Gusev A; Reynolds KL; LeBoeuf NR; Asgari MM; Kwatra SG; Semenov YR
JAMA Dermatol; 2022 Feb; 158(2):189-193. PubMed ID: 35019948
[TBL] [Abstract] [Full Text] [Related]
11. Differential Expression of miR-381-3p in Alzheimer's Disease Patients and Its Role in Beta-Amyloid-Induced Neurotoxicity and Inflammation.
Zhang M; Liu Y; Teng P; Yang Q
Neuroimmunomodulation; 2022; 29(3):211-219. PubMed ID: 34749366
[TBL] [Abstract] [Full Text] [Related]
12. Endoscopic and surgical treatment of T1N0M0 colorectal neuroendocrine tumors: a population-based comparative study.
Zhu H; Zhao S; Zhang C; Ji K; Wu W; Yin L; Yan H; Zhou J; Tang R; Miao L
Surg Endosc; 2022 Apr; 36(4):2488-2498. PubMed ID: 33987767
[TBL] [Abstract] [Full Text] [Related]
13. Relationship Between Apparent Systemic Clearance of Vemurafenib and Toxicity in Patients With Melanoma.
Kichenadasse G; Hughes JH; Fahmy A; Rowland A; Sorich MJ; Hopkins AH
J Clin Pharmacol; 2021 Sep; 61(9):1243-1248. PubMed ID: 33908053
[TBL] [Abstract] [Full Text] [Related]
14. Gamma knife radiosurgery for uveal melanomas and metastases: a systematic review and meta-analysis.
Parker T; Rigney G; Kallos J; Stefko ST; Kano H; Niranjan A; Green AL; Aziz T; Rath P; Lunsford LD
Lancet Oncol; 2020 Nov; 21(11):1526-1536. PubMed ID: 33152286
[TBL] [Abstract] [Full Text] [Related]
15. Reconstruction of lncRNA-miRNA-mRNA network based on competitive endogenous RNA reveals functional lncRNAs in skin cutaneous melanoma.
Zhu J; Deng J; Zhang L; Zhao J; Zhou F; Liu N; Cai R; Wu J; Shu B; Qi S
BMC Cancer; 2020 Sep; 20(1):927. PubMed ID: 32993558
[TBL] [Abstract] [Full Text] [Related]
16. The effects of cannabinoids on glioblastoma growth: A systematic review with meta-analysis of animal model studies.
Luís Â; Marcelino H; Rosa C; Domingues F; Pereira L; Cascalheira JF
Eur J Pharmacol; 2020 Jun; 876():173055. PubMed ID: 32145324
[TBL] [Abstract] [Full Text] [Related]
17. TELEPRO: Patient-Reported Carcinoid Syndrome Symptom Improvement Following Initiation of Telotristat Ethyl in the Real World.
Strosberg J; Joish VN; Giacalone S; Perez-Olle R; Fish-Steagall A; Kapoor K; Dharba S; Lapuerta P; Benson AB
Oncologist; 2019 Nov; 24(11):1446-1452. PubMed ID: 31189618
[TBL] [Abstract] [Full Text] [Related]
18. Switch to anti-programmed cell death protein 1 (anti-PD-1) fixed-dose regimen: What is the economic impact?
Bayle A; Besse B; Annereau M; Bonastre J
Eur J Cancer; 2019 May; 113():28-31. PubMed ID: 30965212
[TBL] [Abstract] [Full Text] [Related]
19. The novel chromatin architectural regulator SND1 promotes glioma proliferation and invasion and predicts the prognosis of patients.
Yu L; Xu J; Liu J; Zhang H; Sun C; Wang Q; Shi C; Zhou X; Hua D; Luo W; Bian X; Yu S
Neuro Oncol; 2019 Jun; 21(6):742-754. PubMed ID: 30753603
[TBL] [Abstract] [Full Text] [Related]
20. 2-(2-(2,4-dioxopentan-3-ylidene)hydrazineyl)benzonitrile as novel inhibitor of receptor tyrosine kinase and PI3K/AKT/mTOR signaling pathway in glioblastoma.
Viswanathan A; Kute D; Musa A; Konda Mani S; Sipilä V; Emmert-Streib F; Zubkov FI; Gurbanov AV; Yli-Harja O; Kandhavelu M
Eur J Med Chem; 2019 Mar; 166():291-303. PubMed ID: 30731398
[TBL] [Abstract] [Full Text] [Related]
[Next]
